Sirolimus use and de novo minimal change nephropathy following renal transplantation [1]

Transplantation

Volumn 80, Issue 12, 2005, Pages 1816-

  Mainra, Rahul ^a   Mulay, Atul ^a   Bell, Robert ^a   Karpinski, Jolanta ^a   Hoar, Stephanie ^a   Knoll, Greg ^a,b   Robertson, Susan ^a   Wang, Don ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAMIPRIL; RANITIDINE; RAPAMYCIN;

ACUTE KIDNEY FAILURE; AGED; CASE REPORT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

AGED; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; SIROLIMUS;

EID: 30144438494     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000181385.68835.a0     Document Type: Letter

References (8)

1. Fervenza FC, Fitzpatrick PM, Mertz J, et al. Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies. Nephrol Dial Transplant 2004; 19: 1288-1292.
2. Lawsin L, Light JA. Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients. Transplantation 2003; 75: 157-160.
3. Butani L. Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue. Transplantation 2004; 78: 1362-1366.
4. Letavernier E, Péraldi MN, Kreis H, et al. Proteinuria following switch from calcineurin inhibitors to sirolimus: a retrospective study. Am J Transplant 2004; 4: 160A.
5. Hayada K, Wissing M, Emine B, et al. Conversion to sirolimus after renal transplantation: high failure rate due to nephrotic proteinuria and other adverse events. J Am Soc Nephrol 2003; 14: 185A.
6. Perlman A, Moore J, Kim E, et al. Clinically significant proteinuria following the administration of sirolimus to renal transplant recipients. J Am Soc Nephrol 2003; 14: 645A.
7. Jim B, Doyle A, Bloom R. Rapamycin is associated with worsening proteinuria in transplant patients with renal injury: a report of four cases. J Am Soc Nephrol 2003; 14: 65A.
8. Dittrich E, Schmaldienst S, Soleiman A, et al. Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy. Transpl Int 2004; 17: 215-220.